Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
15 Feb 1989 to 13 Apr 1989
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1989
Report date:
1989

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
2-(2-heptadec-8-enyl-2-imidazolin-1-yl)ethanol
EC Number:
202-414-9
EC Name:
2-(2-heptadec-8-enyl-2-imidazolin-1-yl)ethanol
Cas Number:
95-38-5
Molecular formula:
C18H34N2O - C24H46N2O
IUPAC Name:
2-(2-heptadec-8-en-1-yl-4,5-dihydro-1H-imidazol-1-yl)ethanol
Constituent 2
Chemical structure
Reference substance name:
(Z)-2-(8-heptadecenyl)-4,5-dihydro-1H-imidazole-1-ethanol
EC Number:
244-501-4
EC Name:
(Z)-2-(8-heptadecenyl)-4,5-dihydro-1H-imidazole-1-ethanol
Cas Number:
21652-27-7
Molecular formula:
C22H42N2O
IUPAC Name:
2-(2-heptadec-8-en-1-yl-4,5-dihydro-1H-imidazol-1-yl)ethanol
Specific details on test material used for the study:
- Substance type: organic
- Physical state: liquid
- Stability under test conditions: stable
- Storage condition of test material: room temperature
- Physical state: Liquid
- Lot/batch No.: 05774HP8

Test animals

Species:
rat
Strain:
other: Tif: RAI f (SPF)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: CIBA-GEIGY Limited, Animal Production, 4332 Stein / Switzerland
- Age at study initiation: 7 to 8 weeks
- Weight at study initiation: 174 to 215 g
- Fasting period before study: Prior to treatment fasted overnight.
- Housing: The rats, segregated by sex, were group-housed (5 animals per cage) in Macrolon cages type 4, with standardized soft wood bedding (Societe Parisienne des Sciures, Pantin).
- Diet: Rat chow (NAFAG 890 Tox, NAFAG, Gossau/SG, Switzerland), ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days before administration

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2 °C
- Humidity (%): 55 +/- 10 %.
- Air changes (per hr): approximately 15 air changes/h
- Photoperiod (hrs dark / hrs light): 12 hour/day light cycle

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
arachis oil
Details on oral exposure:
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg body weight

Doses:
200 mg/kg (females), 500 mg/kg (males and females), and 2000 mg/kg (males)
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations daily; weighing immediately before administration and on days 7, 14, and at death
- Necropsy of survivors performed: yes; Spontaneously dying animals were submitted to a gross necropsy as soon as possible,- survivors at the
end of the observation period.
- Other examinations performed: clinical signs, body weight, organ weights, histopathology
Statistics:
The LD50 values were computed by the logit model (J. Berkson, 1944)

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
ca. 1 000 mg/kg bw
Based on:
test mat.
Sex:
female
Dose descriptor:
LD50
Effect level:
ca. 1 085 mg/kg bw
Based on:
test mat.
Sex:
male/female
Dose descriptor:
LD50
Effect level:
ca. 1 265 mg/kg bw
Based on:
test mat.
Mortality:
Males:
500 mg/kg: 2/5
2000 mg/kg: 3/5

Females:
200 mg/kg: 0/5
500 mg/kg: 1/5
Clinical signs:
other: Piloerection, hunched posture, and dyspnea were seen, being common symptoms in acute tests. Respiratory sounds were noted in animals dosed with 200 and 500 mg/kg. Slightly to moderately reduced locomotor activity was observed in the animals of the 500 and
Gross pathology:
At autopsy, a hemorrhagic thymus was found in one female of the 500 mg/kg dose group. A dilated stomach and a small intestine was found in two males of the same dose group and in three given 2000 mg/kg. The latter three showed also a dilated caecum.

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Executive summary:

Upon an acute oral administration and a 14 day post-treatment observation period, the following LD50 values were determined for the test article:

LD50 in male rats: 1000 mg/kg body weight

LD50 in female rats: 1085 mg/kg body weight

LD50 in rats of both sexes: 1265 mg/kg body -weight (lower 95% confidence limit 505 mg/kg)

Piloerection, hunched posture, and dyspnea were seen, being common symptoms in acute tests. Respiratory sounds were noted in animals dosed with 200 and 500 mg/kg. Slightly to moderately reduced locomotor activity was observed in the animals of the 500 and 2000 mg/kg dose group. A distended abdomen was recorded in single animals of all dose groups. Diarrhea showed one male given 500 and 2000 mg/kg, respectively. The surviving animals of the 500 and 2000 mg/kg bw dose group recovered within 6 to 10 days. At autopsy, a hemorrhagic thymus was found in one female of the 500 mg/kg dose group. A dilated stomach and a small intestine was found in two males of the same dose group and in three given 2000 mg/kg. The latter three showed also a dilated caecum.